Fierce Pharma

AUGUST 6, 2024

Warning of a "silent pandemic" spreading across the globe, Pfizer is taking the fight against antimicrobial resistance (AMR) Down Under. | Pfizer announced Tuesday that it has invested 150 million Australian dollars (about $98 million) to build a new manufacturing facility at its Australian site in Melbourne, where the company will help produce new antimicrobial treatments aimed at addressing the rising tide of antimicrobial resistance.

Manufacturing 331

Manufacturing 331

MedCity News

AUGUST 6, 2024

The FDA approved Servier Pharmaceuticals’ Voranigo as a treatment for two types of low-grade gliomas. The drug, which is projected to become a blockbuster product, comes from Servier’s $1.8 billion acquisition of Agios Pharmaceuticals’ oncology business. The post Big Servier Acquisition Pays Off as FDA Approves Drug for Two Types of Rare Brain Cancer appeared first on MedCity News.

FDA 126

FDA Pharmaceutical Biopharma Pharma 126

Fierce Pharma

AUGUST 6, 2024

Servier has expanded its IDH drug armamentarium with the FDA approval for an IDH1/2 dual inhibitor. | Servier's Voranigo, or vorasidenib, is now the first systemic therapy for low-grade IDH-mutant brain cancer.

FDA 317

FDA 317

MedCity News

AUGUST 6, 2024

Blue Shield of California members can now access the Blue Zones Challenge App, which guides users to adopt the lifestyle habits of people in blue zones— regions known for longer, healthier lives. The post Blue Shield of California Offers Blue Zones App to Encourage Healthier Living appeared first on MedCity News.

119

119

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

AUGUST 6, 2024

Bayer’s transformation under CEO Bill Anderson has picked up momentum. In reporting second-quarter earnings on Tuesday, the company revealed it has cut 3,200 jobs since the start of this year. | Bayer’s transformation under CEO Bill Anderson has picked up momentum. In reporting second-quarter earnings on Tuesday, the company revealed it has cut 3,200 jobs since the start of this year.

303

303

MedCity News

AUGUST 6, 2024

Apple Tree Partners’ latest startup is Red Queen Therapeutics, developer of stapled peptide drugs that block viral fusion. Its lead program is on track for Phase 2 testing in immunocompromised Covid-19 patients; a preclinical pan-influenza program is in development under a BARDA contract. The post Startup Red Queen Therapeutics Unveils $55M and Tech to Defeat Elusive Viral Pathogens appeared first on MedCity News.

Leads 116

Leads Patients Biopharma Pharma 116

pharmaphorum

AUGUST 6, 2024

There's a new source of funding for life science companies, Symbiotic Capital, which is providing credit as an alternative to other financing routes

Biopharma 111

Biopharma 111

Fierce Pharma

AUGUST 6, 2024

Amid Bayer's massive reorganization, the company's pharma group is moving | The company plans to keep building out blockbuster hopeful Nubeqa, popular eye drug Eylea and newer Kerendia as its top-selling Xarelto succumbs to generic competition.

Competition 278

Competition Sales Pharma 278

pharmaphorum

AUGUST 6, 2024

Bristol-Myers Squibb has handed back rights to a TIGIT drug partnered with Agenus, ending an alliance that could have been worth up to $1.56 billion to the biotech.Agenus revealed BMS' decision in a Securities & Exchange Commission (SEC) filing (PDF), saying it was a result of a "broader strategic realignment of their development pipeline which involves other licensed products.

111

111

Fierce Pharma

AUGUST 6, 2024

After previously floating the possibility of div | After previously floating the possibility of divesting Roctavian, BioMarin has decided to keep the hemophilia A gene therapy—but with a narrowed focus. The reorg comes with cost cuts across the medicine's R&D, manufacturing and commercialization support functions.

Marketing 264

Marketing Manufacturing Medicine 264

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

AUGUST 6, 2024

Hospital finances seem to be stabilizing overall. However, a closer look reveals there is a widening gap between the highest- and lowest-performing hospitals, according to a new Kaufman Hall report. The post As Costs Continue to Grow, So Is the Gap Between High- and Low-Performing Hospitals appeared first on MedCity News.

Physicians 108

Physicians 108

Fierce Pharma

AUGUST 6, 2024

Following a string of legal wins this year—plus one major setback in May—GSK has washed its hands of yet another lawsuit alleging the once-popular heartburn med Zantac can cause cancer. | GSK revealed in a statement Monday that it’s emerged victorious in Illinois state court after a jury determined that the company was not liable for a plaintiff’s colorectal cancer.

264

264

MedCity News

AUGUST 6, 2024

With so many now seeking GLP-1 treatment, we must find ways to help providers care for more patients. Technology is the key to unlocking this capacity. The post Rising to the 100M Patient Challenge, Tech’s Role in Scaling Obesity Care appeared first on MedCity News.

Patients 108

Patients Pharma 108

Pharmaceutical Commerce

AUGUST 6, 2024

ROCTAVIAN will only be sold to the United States, Italian, and German markets, as the company eyes its profitability by 2025.

Sales 105

Sales Marketing 105

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

AUGUST 6, 2024

Mallinckrodt agrees to sell Therakos to private equity firm CVC $925m, well below the $1.

105

105

MedCity News

AUGUST 6, 2024

With so much to consider, avoiding hidden and often astronomical costs is a top priority for healthcare leaders. Understanding the totality of an EHR vendor’s offering is crucial, especially since vendors do not cover all the costs of their solutions similarly. The post Avoiding Surprises – Five Key Questions to Ask When Evaluating an EHR Vendor appeared first on MedCity News.

Healthcare 105

Healthcare Healthcare 105

pharmaphorum

AUGUST 6, 2024

Bayer has joined its peers among European drugmakers with a hike in pharma forecasts for the year, as it recorded a rise in group sales but lower profits for the second quarter.Total revenues came in at €11.1 billion ($12.2 billion) in the quarter, ahead of analyst consensus estimates, with pharma leading the charge as it recorded sales up 4.5% to €4.61 billion.

Sales 105

Sales Pharma Leads 105

Pharmaceutical Technology

AUGUST 6, 2024

The recent success of diabetes and weight loss medications has spurred more interest in other metabolic disorders.

Pharma 98

Pharma Medical 98

Advertisement

pharmaphorum

AUGUST 6, 2024

Novartis and Viatris are the latest pharma companies to be sued for allegedly profiting from the unlawful use of HeLa cells derived from Henrietta Lacks

Pharma 105

Pharma 105

Pharmaceutical Technology

AUGUST 6, 2024

GSK has announced the win in the latest trial concerning allegations that its heartburn medication Zantac was linked to cancer.

Medical 98

Medical 98

PharmaTimes

AUGUST 6, 2024

Neurological conditions, including Alzheimer’s disease, are the leading cause of ill health globally

Leads 94

Leads 94

Pharmaceutical Technology

AUGUST 6, 2024

Antengene received approval from the Malaysian National Pharmaceutical Regulatory Agency for XPOVIO NDA for two multiple myeloma indications.

Pharmaceutical 97

Pharmaceutical 97

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTimes

AUGUST 6, 2024

Cardiovascular diseases currently affect around seven million people in the UK, including coronary heart disease

Medical 85

Medical Healthcare Healthcare 85

pharmaphorum

AUGUST 6, 2024

Shares in Actinium Pharmaceuticals have lost almost two-thirds of their value after the FDA asked for a second clinical trial before it would consider reviewing the company's Iomab-B radioligand therapy.

FDA 80

FDA Pharmaceutical 80

Quantified

AUGUST 6, 2024

Stop Expecting New Hires to ‘Figure It Out’ – Invest in Training High turnover and poor performance are costly problems that stem from inadequate onboarding. Companies that fail to invest in proper training for new sales hires often face extended ramp-up times, lower productivity, and higher turnover rates. These issues can be mitigated with the right training programs, specifically by incorporating sales role – play and AI-driven coaching into new hire onboarding.

Training 69

Training Sales Leads Product Knowledge 69

Pharmaceutical Technology

AUGUST 6, 2024

In the global pharmaceutical industry, there were 2 private equity deals announced in Q2 2024, worth a total value of $100m, according to GlobalData's Deals Database.

Electronics 59

Electronics Pharmaceutical Medical 59

Advertisement

Distribution

PharmaVoice

AUGUST 6, 2024

An advisory committee’s age group recommendations look like a major setback, but executives are painting a rosier picture.

59

59

Pharmaceutical Technology

AUGUST 6, 2024

The China-headquartered CDMO is planning to scale its manufacturing operations, expand its presence in APAC, and set up a Swiss subsidiary.

Manufacturing 59

Manufacturing 59

Pharmacy Times

AUGUST 6, 2024

Acalabrutinib plus venetoclax, with or without obinutuzumab, demonstrated significant improvements in progression-free survival.

52

52

PM360

AUGUST 6, 2024

Unless patients have a voice right from product conception and design, new treatments could be poorly aligned with their needs, affecting take-up and commercial success. Unless patient considerations are central to the earliest stages of drug discovery and development—the premise of so-called Patient Focused Drug Development (PFDD)—new treatments or applications of a medicine could fail to make the grade.

Patients 52

Patients Safety Medicine Pharma 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales